- Home
- ARVN vs BLFS Comparison
ARVN vs BLFS Comparison
Compare ARVN & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | BLFS |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 923.5M |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARVN | BLFS |
|---|---|---|
| Price | $10.47 | $19.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 1 |
| Target Price | $15.35 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 763.2K | 501.8K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.84 | ★ 77.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $5.90 | $17.86 |
| 52 Week High | $14.22 | $29.57 |
Technical Indicators
Market Signals| Indicator | ARVN | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 40.63 |
| Support Level | $9.02 | $17.86 |
| Resistance Level | $14.03 | $26.62 |
| Average True Range (ATR) | 0.69 | 0.79 |
| MACD | -0.32 | 0.05 |
| Stochastic Oscillator | 2.36 | 43.17 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.